{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:24:56Z","timestamp":1775841896572,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Identification of COPD patients with a rapid decline in FEV1 is of particular interest for prognostic and therapeutic reasons.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To determine the expression of markers of inflammation in COPD patients with rapid functional decline in comparison to slow or no decliners.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In COPD patients monitored for at least 3\u00a0years (mean\u2009\u00b1\u2009SD: 5.8\u2009\u00b1\u20093\u00a0years) for lung functional decline, the expression and localization of inflammatory markers was measured in bronchial biopsies of patients with no lung functional decline (FEV1%\u2009+\u200930\u2009\u00b1\u200943\u00a0ml\/year, n\u2009=\u200921), slow (FEV1% ml\/year, \u2212\u00a040\u2009\u00b1\u200919, n\u2009=\u200914) and rapid decline (FEV1% ml\/year, \u2212\u00a0112\u2009\u00b1\u200953, n\u2009=\u200915) using immunohistochemistry. ELISA test was used for polymeric immunoglobulin receptor (pIgR) quantitation \u201cin vitro\u201d.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The expression of secretory IgA was significantly reduced in bronchial epithelium (p\u2009=\u20090.011) and plasma cell numbers was significantly reduced in the bronchial lamina propria (p\u2009=\u20090.017) of rapid decliners compared to no decliners. Bronchial inflammatory cell infiltration, CD4, CD8, CD68, CD20, NK, neutrophils, eosinophils, mast cells, pIgR, was not changed in epithelium and lamina propria of rapid decliners compared to other groups. Plasma cells\/mm<jats:sup>2<\/jats:sup> correlated positively with scored total IgA in lamina propria of all patients. \u201cIn vitro\u201d stimulation of 16HBE cells with LPS (10\u00a0\u03bcg\/ml) and IL-8 (10\u00a0ng\/ml) induced a significant increase while H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> (100\u00a0\u03bcM) significantly decreased pIgR epithelial expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These data show an impaired humoral immune response in rapid decliners with COPD, marked by reduced epithelial secretory IgA and plasma cell numbers in the bronchial lamina propria. These findings may help in the prognostic stratification and treatment of COPD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02125-3","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T12:02:50Z","timestamp":1659528170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Decreased humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Antonino","family":"Di Stefano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Dossena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Gnemmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvestro Ennio","family":"D\u2019Anna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Brun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Balbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Piraino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Spanevello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Nucera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitina","family":"Carriero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Maniscalco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Adcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Caramori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio L. M.","family":"Ricciardolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"2125_CR1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD): global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO workshop report. NIH Publication No 2701A. goldcopd.org."},{"key":"2125_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.amjmed.2006.08.002","volume":"119","author":"RA Wise","year":"2006","unstructured":"Wise RA. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression. Am J Med. 2006;119:4\u201311.","journal-title":"Am J Med"},{"key":"2125_CR3","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1001\/jama.1994.03520190043033","volume":"272","author":"NR Anthonisen","year":"1994","unstructured":"Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway A, Enright PL, Kanner RE, O\u2019Hara P, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994;272:1497\u2013505.","journal-title":"JAMA"},{"key":"2125_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1164\/ajrccm.161.2.9901044","volume":"161","author":"PD Scanlon","year":"2000","unstructured":"Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000;161:381\u201390.","journal-title":"Am J Respir Crit Care Med"},{"key":"2125_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/thorax.57.10.847","volume":"57","author":"GC Donaldson","year":"2002","unstructured":"Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847\u201352.","journal-title":"Thorax"},{"issue":"9696","key":"2125_CR6","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0140-6736(09)61298-8","volume":"374","author":"M Decramer","year":"2009","unstructured":"Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP, UPLIFT investigators. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009;374(9696):1171\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(09)61298-8.","journal-title":"Lancet"},{"issue":"4","key":"2125_CR7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1164\/rccm.200712-1869OC","volume":"178","author":"BR Celli","year":"2008","unstructured":"Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178(4):332\u20138. https:\/\/doi.org\/10.1164\/rccm.200712-1869OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2125_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1164\/rccm.201106-0992OC","volume":"185","author":"M Nishimura","year":"2012","unstructured":"Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, Hasegawa M, Shimizu K, Betsuyaku T, Ito YM, Fuke S, Igarashi T, Akiyama Y, Ogura S. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(1):44\u201352. https:\/\/doi.org\/10.1164\/rccm.201106-0992OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7892","key":"2125_CR9","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/s0140-6736(74)90185-8","volume":"2","author":"CM Fletcher","year":"1974","unstructured":"Fletcher CM, Peto R. Letter: screening for diseases of the lung. Lancet. 1974;2(7892):1323\u20134. https:\/\/doi.org\/10.1016\/s0140-6736(74)90185-8.","journal-title":"Lancet"},{"issue":"13","key":"2125_CR10","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1056\/NEJMoa1105482","volume":"365","author":"J Vestbo","year":"2011","unstructured":"Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, MacNee W, Miller BE, Silverman EK, Tal-Singer R, Wouters E, Rennard SI. Changes in forced expiratory volume in 1 second over time in COPD. ECLIPSE Investigators. N Engl J Med. 2011;365(13):1184\u201392. https:\/\/doi.org\/10.1056\/NEJMoa1105482.","journal-title":"N Engl J Med"},{"issue":"1","key":"2125_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3109\/15412550903499530","volume":"7","author":"V Devanarayan","year":"2010","unstructured":"Devanarayan V, Scholand MB, Hoidal J. Identification of distinct plasma biomarker signatures in patients with rapid and slow declining forms of COPD. COPD. 2010;7(1):51\u20138.","journal-title":"COPD"},{"issue":"8","key":"2125_CR12","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.rmed.2009.01.021","volume":"103","author":"Y Higashimoto","year":"2009","unstructured":"Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med. 2009;103(8):1231\u20138. https:\/\/doi.org\/10.1016\/j.rmed.2009.01.021.","journal-title":"Respir Med"},{"issue":"5","key":"2125_CR13","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1021\/ac801745d","volume":"81","author":"M Boutin","year":"2009","unstructured":"Boutin M, Berthelette C, Gervais FG, Scholand MB, Hoidal J, Leppert MF, Bateman KP, Thibault P. High-sensitivity nanoLC-MS\/MS analysis of urinary desmosine and isodesmosine. Anal Chem. 2009;81(5):1881\u20137. https:\/\/doi.org\/10.1021\/ac801745d.","journal-title":"Anal Chem"},{"issue":"19","key":"2125_CR14","doi-asserted-by":"publisher","first-page":"11816","DOI":"10.1016\/S0021-9258(18)33837-7","volume":"257","author":"KE Mostov","year":"1982","unstructured":"Mostov KE, Blobel GJ. A transmembrane precursor of secretory component. The receptor for transcellular transport of polymeric immunoglobulins. Biol Chem. 1982;257(19):11816\u201321.","journal-title":"Biol Chem"},{"issue":"3","key":"2125_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1183\/09031936.01.00228801","volume":"18","author":"C Pilette","year":"2001","unstructured":"Pilette C, Ouadrhiri Y, Godding V, Vaerman JP, Sibille Y. Lung mucosal immunity: immunoglobulin-a revisited. Eur Respir J. 2001;18(3):571\u201388. https:\/\/doi.org\/10.1183\/09031936.01.00228801.","journal-title":"Eur Respir J"},{"issue":"1","key":"2125_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1164\/ajrccm.163.1.9912137","volume":"163","author":"C Pilette","year":"2001","unstructured":"Pilette C, Godding V, Kiss R, Delos M, Verbeken E, Decaestecker C, De Paepe K, Vaerman JP, Decramer M, Sibille Y. Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163(1):185\u201394. https:\/\/doi.org\/10.1164\/ajrccm.163.1.9912137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2125_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1164\/rccm.201010-1629OC","volume":"184","author":"VV Polosukhin","year":"2011","unstructured":"Polosukhin VV, Cates JM, Lawson WE, Zaynagetdinov R, Milstone AP, Massion PP, Ocak S, Ware LB, Lee JW, Bowler RP, Kononov AV, Randell SH, Blackwell TS. Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;184(3):317\u201327. https:\/\/doi.org\/10.1164\/rccm.201010-1629OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2125_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/thx.32.4.387","volume":"32","author":"CA Soutar","year":"1977","unstructured":"Soutar CA. Distribution of plasma cells and other cells containing immunoglobulin in the respiratory tract in chronic bronchitis. Thorax. 1977;32(4):387\u201396. https:\/\/doi.org\/10.1136\/thx.32.4.387.","journal-title":"Thorax"},{"key":"2125_CR19","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/thoraxjnl-2012-203062","volume":"69","author":"A Di Stefano","year":"2014","unstructured":"Di Stefano A, Caramori G, Barczyk A, Vicari C, Brun P, Zanini A, Cappello F, Garofano E, Padovani A, Contoli M, Casolari P, Durham AL, Chung KF, Barnes PJ, Papi A, Adcock I, Balbi B. Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. Thorax. 2014;69:516\u201324. https:\/\/doi.org\/10.1136\/thoraxjnl-2012-203062.","journal-title":"Thorax"},{"issue":"4","key":"2125_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo J, Hurd SS, Agust\u00ed AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347\u201365. https:\/\/doi.org\/10.1164\/rccm.201204-0596PP.","journal-title":"Am J Respir Crit Care Med"},{"key":"2125_CR21","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1183\/09031936.97.10112602","volume":"10","author":"JK Sont","year":"1997","unstructured":"Sont JK, Willems LN, Evertse CE, Hooijer R, Sterk PJ, van Krieken JH. Repeatability of measures of inflammatory cell number in bronchial biopsies in atopic asthma. Eur Respir J. 1997;10:2602\u20138.","journal-title":"Eur Respir J"},{"key":"2125_CR22","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1378\/chest.122.6.1909","volume":"122","author":"K Hattotuwa","year":"2002","unstructured":"Hattotuwa K, Gamble EA, O\u2019Shaughnessy T, Jeffery PK, Barnes NC. Safety of bronchoscopy, biopsy, and BAL in research patients with COPD. Chest. 2002;122:1909\u201312.","journal-title":"Chest"},{"issue":"8","key":"2125_CR23","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1164\/rccm.201604-0759OC","volume":"195","author":"VV Polosukhin","year":"2017","unstructured":"Polosukhin VV, Richmond BW, Du RH, Cates JM, Wu P, Nian H, Massion PP, Ware LB, Lee JW, Kononov AV, Lawson WE, Blackwell TS. Secretory IgA deficiency in individual small airways is associated with persistent inflammation and remodeling. Am J Respir Crit Care Med. 2017;195(8):1010\u201321. https:\/\/doi.org\/10.1164\/rccm.201604-0759OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"2125_CR24","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.2147\/COPD.S141701","volume":"2017","author":"L Millares","year":"2017","unstructured":"Millares L, Mart\u00ed S, Ardanuy C, Li\u00f1ares J, Santos S, Dorca J, Garc\u00eda-Nu\u00f1ez M, Quero S, Mons\u00f3 E. Specific IgA against Pseudomonas aeruginosa in severe COPD. Int J Chron Obstruct Pulmon Dis. 2017;2017(12):2807\u201311. https:\/\/doi.org\/10.2147\/COPD.S141701.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"2125_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1164\/rccm.201311-1971OC","volume":"190","author":"ST Gohy","year":"2014","unstructured":"Gohy ST, Detry BR, Lecocq M, Bouzin C, Weynand BA, Amatngalim GD, Sibille YM, Pilette C. Polymeric immunoglobulin receptor down-regulation in chronic obstructive pulmonary disease. Persistence in the cultured epithelium and role of transforming growth factor-\u03b2. Am J Respir Crit Care Med. 2014;190(5):509\u201321. https:\/\/doi.org\/10.1164\/rccm.201311-1971OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2125_CR26","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1164\/rccm.201802-0352OC","volume":"199","author":"MZ Ladjemi","year":"2019","unstructured":"Ladjemi MZ, Martin C, Lecocq M, Detry B, Nana FA, Moulin C, Weynand B, Fregimilicka C, Bouzin C, Thurion P, Carlier F, Serr\u00e9 J, Gayan-Ramirez G, Delos M, Ocak S, Burgel PR, Pilette C. Increased IgA expression in lung lymphoid follicles in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2019;199(5):592\u2013602. https:\/\/doi.org\/10.1164\/rccm.201802-0352OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"2125_CR27","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1164\/rccm.200602-161OC","volume":"175","author":"J Zhu","year":"2007","unstructured":"Zhu J, Qiu Y, Valobra M, Qiu S, Majumdar S, Matin D, De Rose V, Jeffery PK. Plasma cells and IL-4 in chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(11):1125\u201333. https:\/\/doi.org\/10.1164\/rccm.200602-161OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"2125_CR28","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1164\/rccm.201612-2509ED","volume":"195","author":"JL Curtis","year":"2017","unstructured":"Curtis JL. A hairline crack in the levee: focal secretory IgA deficiency as a first step toward emphysema. Am J Respir Crit Care Med. 2017;195(8):970\u20133. https:\/\/doi.org\/10.1164\/rccm.201612-2509ED.","journal-title":"Am J Respir Crit Care Med"},{"key":"2125_CR29","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.3389\/fimmu.2019.02138","volume":"10","author":"DC Nguyen","year":"2019","unstructured":"Nguyen DC, Joyner CJ, Sanz I, Lee FE. Factors affecting early antibody secreting cell maturation into long-lived plasma cells. Front Immunol. 2019;10:2138. https:\/\/doi.org\/10.3389\/fimmu.2019.02138.","journal-title":"Front Immunol"},{"key":"2125_CR30","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3389\/fimmu.2019.00721","volume":"10","author":"L Khodadadi","year":"2019","unstructured":"Khodadadi L, Cheng Q, Radbruch A, Hiepe F. The maintenance of memory plasma cells. Front Immunol. 2019;10:721. https:\/\/doi.org\/10.3389\/fimmu.2019.00721.","journal-title":"Front Immunol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02125-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02125-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02125-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T12:06:24Z","timestamp":1659528384000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02125-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2125"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02125-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"assertion":[{"value":"11 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study conformed to the Declaration of Helsinki, and was approved by the Institutional Review Boards of Istituti Clinici Scientifici Maugeri (protocol p112).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed written consent and approval for publication in anonymous form was released by all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The sponsors had no role in the design, execution, interpretation, or writing of the study. The authors declare no conflict of interest and absence of competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}